A cationic nanosized hydrogel (nanogel) shows controlled antigen delivery in vivo following intranasal administration and hence holds promise for a clinically effective adjuvant-free and needle-free vaccine system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
WHO Fact Sheet 234 (1999); available at http://www.who.int/inf-fs/en/fact234.html
WHO Fact Sheet 231 (2002); available at http://www.who.int/inf-fs/en/fact231.html
Hutin, Y. J. F. & Chen, R. T. B. World Health Organ. 77, 787–788 (1999).
Levine, M. M. Nature Med. 9, 99–103 (2003).
Logullo, P., Barbosa de Carvalho, H., Saconi, R. & Massad, E. Vaccine 26, 141–143 (2008).
Nochi, T. et al. Nature Mater. 9, 572–578 (2010).
Iwasaki, A. & Medzhitov, R. Science 327, 291–295 (2010).
Sun, J. B., Czerkinsky, C. & Holmgren, J. Scand J. Immunol. 71, 1–11 (2010).
van Ginkel, F. W., Jackson, R. J., Yuki, Y. & McGhee, J. R. J. Immunol. 165, 4778–4782 (2000).
Lewis, D. J. et al. PLoS One 4, e6999 (2009).
Mutsch, M. et al. N. Engl. J. Med. 350, 896–903 (2004).
Akiyoshi, K. et al. J. Control. Release 54, 313–320 (1998).
Ayame, H., Morimoto, N. & Akiyoshi, K. Bioconjug. Chem. 19, 882–890 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Staats, H., Leong, K. Chaperoning vaccines. Nature Mater 9, 537–538 (2010). https://doi.org/10.1038/nmat2788
Issue Date:
DOI: https://doi.org/10.1038/nmat2788